Search Results - "Frolund, U."

THE REVII TRIAL: LENALIDOMIDE AND DEXAMETHASONE AS SECOND LINE TREATMENT IN MYELOMA FOLLOWED BY EXTENDED LENALIDOMID VS LEN/DEX by Lund, J., Gruber, A., Lauri, B., Blimark, C., Swedin, A., Hansson, M., Forsberg, Karin, Ahlberg, L., Carlsson, C., Waage, A., Gimsing, P., Vangsted, A. J., Frolund, U., Hardling, M., Mellqvist, U. H., Nahi, H.

Get full text

Synthesis and Biological Activity of Argiotoxin 636 and Analogues: Selective Antagonists for Ionotropic Glutamate Receptors by Nelson, Jared K, Frølund, Sidsel U, Tikhonov, Dennis B, Kristensen, Anders S, Strømgaard, Kristian

“…More discerning than the parent: Analogues of the polyamine toxin argiotoxin 636 (shown docked in the ion channel of an ionotropic glutamate (iGlu) receptor; N…”
Get full text

Continued improvement in overall survival in elderly multiple myeloma patients after 2008; a population based study from the Danish Multiple Myeloma Registry by Abildgaard, N, Vangsted, A, Gregersen, H, Andersen, N.F, Pedersen, R.S, Plesner, T, Pedersen, P.T, Frederiksen, M, Frølund, U, Helleberg, C, Klausen, T.W, Gimsing, P

Get full text

Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second‐line lenalidomide + dexamethasone induction in multiple myeloma by Lund, Johan, Gruber, Astrid, Lauri, Birgitta, Duru, Adil Doganay, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Carlsson, Conny, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frølund, Ulf, Holmberg, Erik, Gahrton, Gösta, Alici, Evren, Hardling, Mats, Mellqvist, Ulf‐Henrik, Nahi, Hareth

“…Lenalidomide (Len) plus dexamethasone (Dex) is approved for the treatment of relapsed or refractory multiple myeloma (RRMM). It is possible that single‐agent…”
Get full text

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group by Gregersen, Henrik, Peceliunas, Valdas, Remes, Kari, Schjesvold, Fredrik, Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Klausen, Tobias Wirenfeldt, Helleberg, Carsten, Carlson, Kristina, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie Hveding, Crafoord, Jacob, Tsykunova, Galina, Eshoj, Henrik Rode, Waage, Anders, Hansson, Markus, Gulbrandsen, Nina

“…Objective We investigated the efficacy and safety of carfilzomib‐containing induction before salvage high‐dose melphalan with autologous stem‐cell…”
Get full text

Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014 by Helm-Petersen, Sissel, Sørrig, Rasmus, Klausen, Tobias W., Preiss, Birgitte, Frølund, Ulf Christian, Helleberg, Carsten, Breinholt, Marie, Andersen, Mette Klarskov, Abildgaard, Niels, Gimsing, Peter, Vangsted, Annette J.

Get full text

A Randomized Phase 2 Trial Comparing Carfilzomib-Dexamethasone Vs Observation As Maintenance after Induction with Carfilzomib-Cyclophosphamide-Dexamethasone in Salvage ASCT in Multiple Myeloma: A Trial By the Nordic Myeloma Study Group by Gregersen, Henrik, Peceliunas, Valdas, Remes, Kari, Schjesvold, Fredrik H., Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Klausen, Tobias Wirenfeldt, Helleberg, Carsten, Carlson, Kristina, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie Hveding, Linder, Olle, Tsykunova, Galina, Waage, Anders, Hansson, Markus, Gulbrandsen, Nina

“…Background: Salvage autologous stem cell transplantation (ASCT) is used in selected patients with relapsed multiple myeloma after up-front ASCT. However, there…”
Get full text

A Randomized Placebo-Controlled Phase II Study of Clarithromycin or Placebo Combined with VCD Induction Therapy Prior to High-Dose Melphalan with Stem Cell Support in Patients with Newly Diagnosed Multiple Myeloma by Gregersen, Henrik, Abildgaard, Niels, Hieu Do, Trung, Kristensen, Ida Bruun, Frølund, Ulf Christian, Andersen, Niels Frost, Nielsen, Lene Kongsgaard, Andersen, Christen Lykkegaard, Klausen, Tobias Wirenfeldt, Vangsted, Annette Juul

“…▪ Background: Uncontrolled studies and a case-matched study indicate that clarithromycin might exert synergistic effects in combination with thalidomide or…”
Get full text

Health-related quality of life in multiple myeloma patients with first relapse treated with Carfilzomib-based re-induction and salvage autologous stem cell transplantation: data from a Nordic phase II trial by Eshoj, Henrik Rode, Nielsen, Lene Kongsgaard, Schjesvold, Fredrik, Abildgaard, Niels, Nahi, Hareth, Andersen, Niels Frost, Vangsted, Annette Juul, Helleberg, Carsten, Frølund, Ulf Christian, Axelsson, Per, Stromberg, Olga, Blimark, Cecilie, Carlson, Kristina, Waage, Anders, Remes, Kari, Peceliunas, Valdas, Guldbrandsen, Nina, Hansson, Markus, Gregersen, Henrik

Get full text

APO010 sensitivity in relapsed multiple myeloma patients by Vangsted, A.J., Jensen, P.B., Madsen, M.W., Gimsing, P., Jensen, T., Hansen, A., Rasmussen, A., Nielsen, A., Buhl, U., Jandu, H., Brunner, N., Pratt, B., Frølund, U.C., Helleberg, C., Abildgaard, N., Knudsen, S.

Get full text

The Rev II Trial: Lenalidomide and Dexamethasone As Second Line Treatment in Myeloma Followed By Extended Lenalidomid Vs Len/Dex by Lund, Johan, Karstorp, Sigrid, Alici, Evren, Gruber, Astrid, Lauri, Birgitta, Blimark, Cecilie, Swedin, Agneta, Hansson, Markus, Forsberg, Karin, Ahlberg, Lucia, Conny, Carlsson, Waage, Anders, Gimsing, Peter, Vangsted, Annette Juul, Frølund, Ulf Christian, Hardling, Mats, Mellqvist, Ulf-Henrik, Nahi, Hareth

“…Background The indication for use of lenalidomide in second line of therapy has been based upon two phase III studies comparing lenalidomide and dexamethasone…”
Get full text

The Danish National Multiple Myeloma Registry by Gimsing, Peter, Holmström, Morten O, Klausen, Tobias Wirenfelt, Andersen, Niels Frost, Gregersen, Henrik, Pedersen, Robert Schou, Plesner, Torben, Pedersen, Per Trøllund, Frederiksen, Mikael, Frølund, Ulf, Helleberg, Carsten, Vangsted, Annette, de Nully Brown, Peter, Abildgaard, Niels

“…The Danish National Multiple Myeloma Registry (DMMR) is a population-based clinical quality database established in January 2005. The primary aim of the…”
Get full text

Inside Cover: Synthesis and Biological Activity of Argiotoxin 636 and Analogues: Selective Antagonists for Ionotropic Glutamate Receptors (Angew. Chem. Int. Ed. 17/2009) by Nelson, Jared K., Frølund, Sidsel U., Tikhonov, Dennis B., Kristensen, Anders S., Strømgaard, Kristian

“…Abstract Spiders of the genus Argiope , such as Argiope lobata , contain polyamine toxins that are potent but nonselective blockers of glutamate receptors…”
Get full text

Innentitelbild: Synthesis and Biological Activity of Argiotoxin 636 and Analogues: Selective Antagonists for Ionotropic Glutamate Receptors (Angew. Chem. 17/2009) by Nelson, Jared K., Frølund, Sidsel U., Tikhonov, Dennis B., Kristensen, Anders S., Strømgaard, Kristian

“…Spinnen der Gattung Argiope beispielsweise die Argiope lobata, setzen giftige Polyamine ein, die Glutamat‐Rezeptoren stark, aber nicht selektiv blockieren…”
Get full text

Synthesis and Biological Activity of Argiotoxin 636 and Analogues: Selective Antagonists for Ionotropic Glutamate Receptors by Nelson, Jared K., Frølund, Sidsel U., Tikhonov, Dennis B., Kristensen, Anders S., Strømgaard, Kristian

“…Wählerischer als die Stammverbindung: Analoga des Polyamin‐Toxins Argiotoxin 636 (im Bild im Ionenkanal des ionotropen Glutamat(iGlu)‐Rezeptors; N blau, O rot)…”
Get full text

Innentitelbild: Synthesis and Biological Activity of Argiotoxin 636 and Analogues: Selective Antagonists for Ionotropic Glutamate Receptors (Angew. Chem. 17/2009) by Nelson, Jared K., Frølund, Sidsel U., Tikhonov, Dennis B., Kristensen, Anders S., Strømgaard, Kristian

“…Abstract Spinnen der Gattung Argiope beispielsweise die Argiope lobata , setzen giftige Polyamine ein, die Glutamat‐Rezeptoren stark, aber nicht selektiv…”
Get full text